Tweets
Applying updated ACR guidelines in real life isn’t always straightforward.
Two experts share insights on managing lupus nephritis beyond the textbook.
Sponsored by Aurinia https://t.co/7NAJW3LoSM https://t.co/h5RHK290pD
Dr. John Cush @RheumNow ( View Tweet )
5 hours 59 minutes ago
Advanced Practice Rheum: Safety of Biologics and Novel Agents
Dr. Jack Cush reviews safety of biologics and novel agents. This video is part of the Advanced Practice Rheum series.
https://t.co/K5TiwFA0L2 https://t.co/XoFsTMnxPC
Dr. John Cush @RheumNow ( View Tweet )
7 hours 30 minutes ago
DERM on RheumNow PODCAST (May 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, and other CTD skin disorders. Dermatology drugs, biologics, JAKs - their use, efficacy, and https://t.co/0AEAxadBFT
Dr. John Cush @RheumNow ( View Tweet )
10 hours 59 minutes ago
Count Your Telangiectasias (5.29.2026)
Dr. Jack Cush reviews the news, journal articles and missed quiz questions.
https://t.co/KDXijQMdfr https://t.co/2Vi3MKZZbk
Dr. John Cush @RheumNow ( View Tweet )
12 hours 59 minutes ago
RA comorbidities are changing. ILD, anxiety, depression increasing. Less extraartic. manifestations, CA & CV dz. Consider screening for cervical CA, ILD, CV dz & OP (for pts on steroids) https://t.co/WVITFXNva7 https://t.co/tggdaO9RJB
Dr. John Cush @RheumNow ( View Tweet )
14 hours 30 minutes ago
Congratulations to Professor Dennis McGonagle for being awarded the prestigious Heberden Oration Award at the 2026 British Society for Rheumatology (BSR) Conference. https://t.co/TOG5Y9tNrW https://t.co/3aumO6Z3A9
Dr. John Cush @RheumNow ( View Tweet )
15 hours 59 minutes ago
Curcumin in arthritis may have NSAID like clinical efficacy. But how? Metanalysis lays out the multiple potential effects for it to inhibit inflammatory signaling pathways (NF-κB, TNF-α, IL-1β, IL-6, COX-2, and PGE2) https://t.co/gSYVwpl41P https://t.co/0xZdyiF4QN
Dr. John Cush @RheumNow ( View Tweet )
1 day 5 hours ago
Increased Polypharmacy in SLE Patients
A cross-sectional study of US adults with systemic lupus erythematosus (SLE) shows significantly increased prevalence of polypharmacy, related to age, disease outcomes and often, non-SLE common medications.
https://t.co/3Mo3O8Ra04 https://t.co/zRS8TmFvvf
Dr. John Cush @RheumNow ( View Tweet )
1 day 6 hours ago
APR: Biologics and DMARD Safety
Companion slide deck for the Advanced Practice Rheum: Safety of Biologics and Novel Agents video.
https://t.co/EbbbUC2dK5 https://t.co/1hEATEH4kP
Dr. John Cush @RheumNow ( View Tweet )
1 day 10 hours ago
Multisystem inflammatory syndrome in children (MIS-C) - analysis of cases 2023-2024 shows 99% were undervaccinated against COVID-19. OVer 2 yrs, 141 MIS-C 78%had no COVID-19 vaccine. All 4 children who died were unvaccinated https://t.co/iBcA4GIdDe https://t.co/IQLLaG55gm
Dr. John Cush @RheumNow ( View Tweet )
1 day 13 hours ago
Integrating D2T into T2T Practices in RA
Researchers at Semmelweis University analyzed how depression, smoking, obesity, sleep disorders, and other health problems are linked to difficult-to-treat rheumatoid arthritis (D2T-RA) and how this can inform treat-to-target (T2T) and https://t.co/buCXeK2jNS
Dr. John Cush @RheumNow ( View Tweet )
1 day 13 hours ago
True or False: NLRP3 inflammasome activation in neutrophils triggers PAD release, increasing citrullination of intracellular proteins and contributing to rheumatoid arthritis pathogenesis. See if you got it right in this week's RheumIQ quiz at https://t.co/DX0qT1iNF2 https://t.co/rVuQM3aeI2
Dr. John Cush @RheumNow ( View Tweet )
1 day 15 hours ago


